Hung‐Ming Wang

862 total citations
20 papers, 530 citations indexed

About

Hung‐Ming Wang is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hung‐Ming Wang has authored 20 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Otorhinolaryngology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Hung‐Ming Wang's work include Head and Neck Cancer Studies (13 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Hung‐Ming Wang is often cited by papers focused on Head and Neck Cancer Studies (13 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Hung‐Ming Wang collaborates with scholars based in Taiwan, China and Singapore. Hung‐Ming Wang's co-authors include Chia‐Hsun Hsieh, Wen-Pin Chou, Tzu-Keng Chiu, Min‐Hsien Wu, Joseph Tung‐Chieh Chang, Chun‐Ta Liao, Yung‐Chang Lin, Shu‐Hang Ng, Tzu‐Chen Yen and Sheng-Chieh Chan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Hung‐Ming Wang

20 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hung‐Ming Wang Taiwan	13	172	163	137	113	81	20	530
Miel Wouters Netherlands	5	122 0.7×	52 0.3×	106 0.8×	189 1.7×	6 0.1×	10	355
Lih‐Yu Chang Taiwan	12	58 0.3×	21 0.1×	68 0.5×	163 1.4×	24 0.3×	29	468
Ruidan Li China	10	60 0.3×	40 0.2×	26 0.2×	56 0.5×	10 0.1×	44	278
Elisa Placidi Italy	13	81 0.5×	37 0.2×	19 0.1×	71 0.6×	91 1.1×	42	471
Renita Castelino India	9	36 0.2×	31 0.2×	15 0.1×	43 0.4×	14 0.2×	77	299
Daniela Wagner Germany	13	16 0.1×	34 0.2×	43 0.3×	206 1.8×	139 1.7×	29	569
Ayako Sugano Japan	8	33 0.2×	74 0.5×	57 0.4×	33 0.3×	10 0.1×	14	356
Shubha Gurudath India	9	37 0.2×	68 0.4×	35 0.3×	23 0.2×	35 0.4×	16	298
Gurdarshan S. Sandhu United States	12	95 0.6×	9 0.1×	96 0.7×	203 1.8×	37 0.5×	30	489

Countries citing papers authored by Hung‐Ming Wang

Since Specialization

Citations

This map shows the geographic impact of Hung‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Ming Wang more than expected).

Fields of papers citing papers by Hung‐Ming Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Ming Wang. The network helps show where Hung‐Ming Wang may publish in the future.

Co-authorship network of co-authors of Hung‐Ming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Ming Wang. A scholar is included among the top collaborators of Hung‐Ming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Ming Wang. Hung‐Ming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Qiuyan, Hai‐Qiang Mai, Dongping Chen, et al.. (2024). Four-year overall survival follow-up and dynamic EBV titer analysis of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (r/m NPC).. Journal of Clinical Oncology. 42(16_suppl). 6039–6039. 2 indexed citations

Lu, Chang‐Hsien, Chih–Chung Hsu, Kun‐Yun Yeh, et al.. (2023). Effect of prophylactic tube feeding in head and neck cancer patients with high Mallampati score undergoing definitive concurrent chemoradiotherapy. Supportive Care in Cancer. 31(7). 384–384. 1 indexed citations

Mai, Hai‐Qiang, Qiuyan Chen, Dongping Chen, et al.. (2023). Final overall survival analysis of JUPITER-02: A phase 3 study of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC).. Journal of Clinical Oncology. 41(16_suppl). 6009–6009. 4 indexed citations

Mai, Hai‐Qiang, Qiuyan Chen, Dong‐Ping Chen, et al.. (2022). Abstract CT226: Final progression-free survival analysis of JUPITER-02, a randomized, double-blind, phase 3 study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma. Cancer Research. 82(12_Supplement). CT226–CT226. 6 indexed citations

Hung, Chia‐Yen, Chang‐Hsien Lu, Ping‐Tsung Chen, et al.. (2020). A prospective nutritional assessment using Mini Nutritional Assessment-short form among patients with head and neck cancer receiving concurrent chemoradiotherapy. Supportive Care in Cancer. 29(3). 1509–1518. 14 indexed citations

Hsieh, Chia‐Hsun, Chien‐Yu Lin, Cheng‐Lung Hsu, et al.. (2019). Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial. Journal of Cancer Research and Clinical Oncology. 146(1). 33–41. 29 indexed citations

Huang, Pei‐Wei, Chien-Yu Lin, Chia‐Hsun Hsieh, et al.. (2018). A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx. Biomedical Journal. 41(2). 129–136. 21 indexed citations

Chiu, Tzu-Keng, Wen-Pin Chou, Song-Bin Huang, et al.. (2016). Application of optically-induced-dielectrophoresis in microfluidic system for purification of circulating tumour cells for gene expression analysis- Cancer cell line model. Scientific Reports. 6(1). 32851–32851. 78 indexed citations

Chou, Wen-Pin, Hung‐Ming Wang, Tzu-Keng Chiu, et al.. (2016). The utilization of optically-induced-dielectrophoresis (ODEP)-based virtual cell filters in a microfluidic system for continuous isolation and purification of circulating tumour cells (CTCs) based on their size characteristics. Sensors and Actuators B Chemical. 241. 245–254. 77 indexed citations

10.

Chou, Wen‐Chi, Yu‐Shin Hung, Chen‐Yi Kao, et al.. (2013). Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Supportive Care in Cancer. 21(7). 1973–1981. 24 indexed citations

11.

Yeh, Kun‐Yun, Hung‐Ming Wang, John W. C. Chang, et al.. (2013). Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(1). 41–48. 54 indexed citations

12.

Kao, Chen‐Yi, Yu‐Shin Hung, Po‐Jung Su, et al.. (2012). Validation of a Palliative Prognostic Index to Predict Life Expectancy for Terminally Ill Cancer Patients in a Hospice Consultation Setting in Taiwan. Asian Pacific Journal of Cancer Prevention. 13(6). 2861–2866. 27 indexed citations

13.

Huang, Shiang‐Fu, et al.. (2012). The Mitochondrial DNA Northeast Asia CZD Haplogroup Is Associated with Good Disease-Free Survival among Male Oral Squamous Cell Carcinoma Patients. PLoS ONE. 7(11). e49684–e49684. 7 indexed citations

14.

Chan, Sheng-Chieh, Hung‐Ming Wang, Shu‐Hang Ng, et al.. (2012). Utility of¹⁸F-Fluoride PET/CT and¹⁸F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients. Journal of Nuclear Medicine. 53(11). 1730–1735. 14 indexed citations

15.

Grégoire, Vincent, Marc Hamoir, Changhu Chen, et al.. (2011). Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study. Radiotherapy and Oncology. 100(1). 62–69. 35 indexed citations

16.

Chan, Sheng-Chieh, Joseph Tung‐Chieh Chang, Chien‐Yu Lin, et al.. (2011). Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma. Nuclear Medicine Communications. 32(11). 989–996. 61 indexed citations

17.

Chen, Yin‐Ju, Chun‐Ta Liao, Po‐Jen Chen, et al.. (2010). Downregulation of Ches1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head & Neck. 33(2). 257–266. 24 indexed citations

18.

Ng, Shu‐Hang, Sheng-Chieh Chan, Tzu‐Chen Yen, et al.. (2009). Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT. European Radiology. 19(12). 2965–2976. 36 indexed citations

19.

Chou, Wen‐Chi, Shiu-Feng Huang, Hung‐Ming Wang, et al.. (2006). Different Responses to Gefitinib in Lung Adenocarcinoma Coexpressing Mutant- and Wild-Type Epidermal Growth Factor Receptor Genes. Japanese Journal of Clinical Oncology. 36(8). 523–526. 8 indexed citations

20.

Wang, Hung‐Ming, Shu‐Hang Ng, Cheng-Hsu Wang, et al.. (1996). Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent. Cancer. 78(9). 1972–1979. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact